Premature Ovarian Failure 2a C1845293
Premature Ovarian Failure 2a is a genetic form of ovarian dysfunction where ovaries stop working before age 40. It affects women and is managed with hormone replacement therapy and fertility support.
Key facts at a glance
- ICD-10
- E34.9
- ICD-11
- 5A00.0
- Body system
- endocrine
- Severity
- moderate
- Chronic
- true
Signs and symptoms
Common signs and symptoms that may indicate this condition.
Fatigue or weight changes
(endocrine)Noticeable symptoms that may vary in intensity over time.
Frequency: Common at all stages
Irregular menstrual cycles
(endocrine)Hot flashes
(endocrine)Vaginal dryness
(endocrine)Joint pain
(endocrine)Diagnosis and tests
How this condition is diagnosed and what test results mean.
Initial screening tests
Standard diagnostic workup
Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]
Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]
Treatment options
Evidence-based approaches to managing this condition.
First-line treatments
Endocrine management
Treatment options should be discussed with a qualified healthcare provider.
Hormone replacement therapy (HRT)
Individualized estrogen and progestogen replacement to restore hormonal milieu, alleviate vasomotor symptoms, and protect bone and cardiovascular systems. Transdermal delivery may be preferred to minimize thrombotic risk.
Bone health nutritional support
Comprehensive approach including calcium-rich foods, vitamin D supplementation, and avoidance of excessive caffeine, sodium, and alcohol which can negatively impact bone density.
Additional treatment options
Comprehensive endocrine monitoring
Regular assessment of FSH, estradiol levels, thyroid function, adrenal antibodies, and metabolic markers to monitor disease progression and treatment adequacy.
monitoringPhytoestrogen and herbal supplementation
Limited evidence supports use of soy isoflavones or black cohosh for mild symptom management; however, these should not replace conventional HRT in confirmed POI.
complementaryPsychosocial support and identity counseling
Support for emotional adjustment to diagnosis, particularly given genetic associations with type 2A. Addresses impact on relationships, sexuality, and long-term life planning.
psychologicalMedication Comparisons
Compare medications used to treat Premature Ovarian Failure 2a C1845293. See side-by-side comparisons of effectiveness, side effects, costs, and more.
View Medication ComparisonsThis information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.
This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.
If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.
Medically reviewed by WellAlly Editorial Team Last reviewed August 25, 2026. · Read our editorial policy